Deutsche Bank’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,168
Closed -$67K 4842
2021
Q1
$67K Sell
1,168
-115
-9% -$7.49K ﹤0.01% 4158
2020
Q4
$58K Buy
1,283
+364
+40% +$17.5K ﹤0.01% 4075
2020
Q3
$46K Buy
919
+87
+10% +$4.72K ﹤0.01% 3930
2020
Q2
$51K Buy
+832
New +$50.3K ﹤0.01% 3816
2018
Q4
Sell
-61
Closed -$3K 5470
2018
Q3
$3K Buy
+61
New +$4.13K ﹤0.01% 5230

Other funds holding ORGS

Deutsche Bank's ORGS Position: Q2 2021 in Review

Deutsche Bank sold out of Orgenesis Inc. Common Stock (ORGS) in Q2 2021, closing a stake of 1,168 shares — an estimated $67K sold.

Deutsche Bank first reported a position in ORGS in Q3 2018 and held it in 5 quarters. The position peaked at $67K in Q1 2021. 33 funds tracked by Wall St. Rank hold ORGS as of Q2 2021.

  • Deutsche Bank reported no remaining Orgenesis Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Deutsche Bank sold 1,168 Orgenesis Inc. Common Stock shares in Q2 2021, an estimated $67K.
  • Deutsche Bank first reported a position in Orgenesis Inc. Common Stock in Q3 2018 and held it in 5 quarters.
  • Deutsche Bank's Orgenesis Inc. Common Stock position peaked at $67K in Q1 2021.
  • 33 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.